BRPI0612005A2 - agente profilático ou terapêutico, composição oftalmológica, uso de selenoproteína p, e, método de prevenção/tratamento de uma doença corneal/conjuntival - Google Patents
agente profilático ou terapêutico, composição oftalmológica, uso de selenoproteína p, e, método de prevenção/tratamento de uma doença corneal/conjuntivalInfo
- Publication number
- BRPI0612005A2 BRPI0612005A2 BRPI0612005A BRPI0612005A BRPI0612005A2 BR PI0612005 A2 BRPI0612005 A2 BR PI0612005A2 BR PI0612005 A BRPI0612005 A BR PI0612005A BR PI0612005 A BRPI0612005 A BR PI0612005A BR PI0612005 A2 BRPI0612005 A2 BR PI0612005A2
- Authority
- BR
- Brazil
- Prior art keywords
- selenoprotein
- corneal
- prophylactic
- treating
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1761—Apoptosis related proteins, e.g. Apoptotic protease-activating factor-1 (APAF-1), Bax, Bax-inhibitory protein(s)(BI; bax-I), Myeloid cell leukemia associated protein (MCL-1), Inhibitor of apoptosis [IAP] or Bcl-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Marine Sciences & Fisheries (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005182597 | 2005-06-22 | ||
PCT/JP2006/312392 WO2006137426A1 (ja) | 2005-06-22 | 2006-06-21 | 角結膜疾患の予防又は治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0612005A2 true BRPI0612005A2 (pt) | 2016-09-06 |
Family
ID=37570453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0612005A BRPI0612005A2 (pt) | 2005-06-22 | 2006-06-21 | agente profilático ou terapêutico, composição oftalmológica, uso de selenoproteína p, e, método de prevenção/tratamento de uma doença corneal/conjuntival |
Country Status (10)
Country | Link |
---|---|
US (1) | US20100113338A1 (pt) |
EP (1) | EP1915998A4 (pt) |
JP (1) | JPWO2006137426A1 (pt) |
KR (1) | KR20080031195A (pt) |
CN (1) | CN101203236A (pt) |
AU (1) | AU2006260184B2 (pt) |
BR (1) | BRPI0612005A2 (pt) |
CA (1) | CA2613247A1 (pt) |
RU (1) | RU2008102249A (pt) |
WO (1) | WO2006137426A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012067525A1 (en) | 2010-11-18 | 2012-05-24 | Pomorski Uniwersytet Medyczny | Genotypes and selenium level as a markers of breast/ovarian cancer risk in brca1 mutation carriers |
PL394194A1 (pl) | 2011-03-14 | 2011-09-12 | Read-Gene Spółka Akcyjna | Genotypy selenoprotein jak również poziomy selenu w organizmach i w naturalnej diecie jako kluczowe czynniki ryzyka raków u ludzi |
EA201391595A1 (ru) | 2011-05-20 | 2014-06-30 | Кейо Юниверсити | Новый металлопротеин, способ его получения и профилактический или терапевтический агент при заболеваниях роговицы или конъюнктивы, содержащий указанный металлопротеин |
US20170182085A1 (en) * | 2014-07-14 | 2017-06-29 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for keratoconjunctive disorder |
US9463201B2 (en) | 2014-10-19 | 2016-10-11 | M.G. Therapeutics Ltd | Compositions and methods for the treatment of meibomian gland dysfunction |
EP3313413A4 (en) * | 2015-09-28 | 2018-07-11 | Azura Opthalmics Ltd. | Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion |
EP3445352A4 (en) * | 2016-04-19 | 2019-12-11 | Azura Opthalmics Ltd. | COMPOSITIONS FOR THE TREATMENT OF HYPERKERATOSIS RELATED DISORDERS |
JP7142286B2 (ja) * | 2018-07-13 | 2022-09-27 | 慶應義塾 | セレン含有アミノ酸を含む糖鎖-ポリペプチド複合体、および、その医薬用途 |
CN109498795A (zh) * | 2018-10-30 | 2019-03-22 | 颜廷乐 | 一种眼部抑菌护理液及其制备方法 |
CA3166357A1 (en) | 2020-01-10 | 2021-07-15 | Azura Ophthalmics Ltd. | Instructions for composition and sensitivity |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10330257A (ja) * | 1997-06-02 | 1998-12-15 | Senju Pharmaceut Co Ltd | 眼局所用サイトカイン産生抑制剤 |
US20050143310A1 (en) * | 2001-05-11 | 2005-06-30 | Masaki Hirashima | Novel remedies for neurodegenerative disease |
JP2004182616A (ja) * | 2002-11-29 | 2004-07-02 | Chemo Sero Therapeut Res Inst | 新規な神経伝達機能異常疾患改善剤 |
JP4599028B2 (ja) * | 2002-12-05 | 2010-12-15 | 一般財団法人化学及血清療法研究所 | 新規な炎症性疾患改善剤 |
-
2006
- 2006-06-21 WO PCT/JP2006/312392 patent/WO2006137426A1/ja active Application Filing
- 2006-06-21 KR KR1020077029841A patent/KR20080031195A/ko not_active Application Discontinuation
- 2006-06-21 EP EP06767051A patent/EP1915998A4/en not_active Withdrawn
- 2006-06-21 CA CA002613247A patent/CA2613247A1/en not_active Abandoned
- 2006-06-21 AU AU2006260184A patent/AU2006260184B2/en not_active Ceased
- 2006-06-21 BR BRPI0612005A patent/BRPI0612005A2/pt not_active IP Right Cessation
- 2006-06-21 US US11/993,580 patent/US20100113338A1/en not_active Abandoned
- 2006-06-21 CN CNA2006800206864A patent/CN101203236A/zh active Pending
- 2006-06-21 RU RU2008102249/15A patent/RU2008102249A/ru unknown
- 2006-06-21 JP JP2007522308A patent/JPWO2006137426A1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1915998A1 (en) | 2008-04-30 |
RU2008102249A (ru) | 2009-07-27 |
WO2006137426A1 (ja) | 2006-12-28 |
AU2006260184A1 (en) | 2006-12-28 |
CN101203236A (zh) | 2008-06-18 |
US20100113338A1 (en) | 2010-05-06 |
JPWO2006137426A1 (ja) | 2009-01-22 |
CA2613247A1 (en) | 2006-12-28 |
KR20080031195A (ko) | 2008-04-08 |
EP1915998A4 (en) | 2009-11-18 |
AU2006260184B2 (en) | 2011-05-12 |
EP1915998A8 (en) | 2008-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0612005A2 (pt) | agente profilático ou terapêutico, composição oftalmológica, uso de selenoproteína p, e, método de prevenção/tratamento de uma doença corneal/conjuntival | |
TWI369996B (en) | Ophthalmic compositions and methods for treating eyes | |
EP1732484A4 (en) | OPHTHALMIC IMPLANT FOR THE TREATMENT OF GLAUCOMA | |
EP1742641A4 (en) | METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF RETINA DISEASES | |
WO2008029276A8 (en) | Compositions and methods for the treatment of ophthalmic disease | |
GEP20094781B (en) | Sulfonamide derivatives for the treatment of diseases | |
SI1884234T1 (sl) | Profilaktično ali terapevtsko sredstvo za kornealno in konjunktivalno motnjo | |
IS7215A (is) | Aðferðir til að meðhöndla nýæðarsjúkdóma í augum | |
EP1796675A4 (en) | COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISEASES | |
BRPI0508451A (pt) | método de tratamento de linfoma não-hodgkin em um mamìfero, usos de uma combinação de cci-779 e rituximab e de uma combinação de um inibidor de mtor e rituximab, produtos contendo cci-779 e rituximab e um inibidor mtor e rituximab, embalagem farmacêutica, e, composição farmacêutica | |
ATE529417T1 (de) | 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält | |
WO2006138048A3 (en) | Formulations comprising fluphenazine or derivatives thereof | |
WO2005020928A3 (en) | Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins | |
BRPI0612624A2 (pt) | métodos para tratar doença vascular em um humano, e para prevenção e/ou tratamento de uma doença induzida por trombose ou uma doença induzida por tromboembolismo em um humano, e, uso de um composto | |
WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
EP1545555A4 (en) | COMPOSITIONS AND METHODS FOR TREATING EPITHELIAL AND RETINAL TISSUE DISEASES | |
GB0523961D0 (en) | The treatment of ophthalmic diseases | |
FR2883182B1 (fr) | Composition de vitamines utiles dans le traitement des maladies oculaires | |
WO2007061924A3 (en) | Methods of treating cartilage defects | |
BRPI0607684A2 (pt) | composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida | |
MXPA03009273A (es) | AGENTE PARA EL TRATAMIENTO OFTaLMICO TOPICO DE LAS ENFERMEDADES INFLAMATORIAS OCULARES. | |
EP1542664A4 (en) | METHODS AND COMPOSITIONS FOR TREATING MACULAR AND RETINAL DISORDERS | |
WO2004091436A3 (en) | Methods and compositions for treating ocular disease | |
NL1025844A1 (nl) | Benzopyranverbindingen voor gebruik bij de behandeling en preventie van ontstekingsgerelateerde aandoeningen. | |
EP1664775A4 (en) | COMPOSITION FOR THE DIAGNOSIS OF RETINAL VASCULAR DISEASE COMPRISING ALDOLASE AND DIAGNOSTIC METHOD USING THE SAME |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 PAR 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA. |
|
B11Z | Dismissal: petition dismissal - article 216, par 2 of industrial property law |
Free format text: REFERENTE A PETICAO NO 20070182819/RJ DE 21/12/2007. |
|
B06H | Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette] |
Free format text: O DESPACHO 6.7 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0. |
|
B11M | Decision cancelled [chapter 11.13 patent gazette] |
Free format text: O DESPACHO 11.6.1 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0. |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |